首页> 外文期刊>The Journal of biological chemistry >c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice
【24h】

c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice

机译:C-JUN N-末端激酶(JNK) - 乙酰氨基酚或肿瘤坏死因子(TNF)的依赖性急性肝损伤需要小鼠的线粒体SAB蛋白表达

获取原文
           

摘要

Sustained JNK activation plays a critical role in hepatotoxicity by acetaminophen or GalN/TNF-α. To address the importance of JNK translocation to mitochondria that accompanies sustained activation in these models, we assessed the importance of the expression of a potential initial target of JNK in the outer membrane of mitochondria, namely Sab (SH3 domain-binding protein that preferentially associates with Btk), also known as Sh3bp5 (SH3 domain-binding protein 5). Silencing the expression of Sab in the liver using adenoviral shRNA inhibited sustained JNK activation and mitochondrial targeting of JNK and the upstream MKK4 (MAPK kinase 4), accompanied by striking protection against liver injury in vivo and in cultured hepatocytes in both toxicity models. We conclude that mitochondrial Sab may serve as a platform for the MAPK pathway enzymes and that the interaction of stress-activated JNK with Sab is required for sustained JNK activation and toxicity.
机译:持续的JNK活化通过乙酰氨基酚或GALN / TNF-α在肝毒性中起着关键作用。为了解决JNK易位对线粒体的重要性,这些模型中持续激活的线粒体,我们评估了在线粒体外膜中表达JNK的潜在初始靶标的表达的重要性,即SAB(优先与之相关联的SH3结构域结合蛋白质BTK),也称为SH3BP5(SH3结构域结合蛋白5)。使用腺病毒ShRNA抑制肝脏ShRNA在肝脏中的表达抑制了JNK和上游MKK4(MAPK激酶4)的持续的JNK活化和线粒体靶向,并伴随着对体内肝损伤和毒性模型中的肝损伤的保护。我们得出结论,线粒体SAB可以用作MAPK途径酶的平台,并且需要持续的JNK活化和毒性胁迫激活的JNK与SAb的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号